Skip to main content

Advertisement

Log in

Treatment Options for Chronic Prostatitis due to Vancomycin-Resistant Enterococcus faecium

  • Note
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

 Prostatitis due to vancomycin-resistant enterococci has not been previously described. Reported here is a case of chronic prostatitis due to Enterococcus faecium, resistant to vancomycin, ampicillin, ciprofloxacin and doxycycline, in a 42-year-old liver transplant recipient. Treatment with a combination of rifampin and nitrofurantoin for 6 weeks resulted in long-lasting cure. Other antimicrobial agents active in vitro against vancomycin-resistant enterococci, such as quinupristin/dalfopristin and chloramphenicol, are unlikely to achieve sufficient prostatic tissue levels to be successfully utilized for treatment of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, S., Paterson, D. & Yu, V. Treatment Options for Chronic Prostatitis due to Vancomycin-Resistant Enterococcus faecium . EJCMID 17, 798–800 (1998). https://doi.org/10.1007/s100960050190

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100960050190

Keywords

Navigation